Abstract
The revolution in cancer research can be summed up in a single sentence: cancer is, in essence, a genetic disease. In the last decade, many important genes responsible for the genesis of various cancers have been discovered, their mutations precisely identified, and the pathways through which they act characterized. The purposes of this review are to highlight examples of progress in these areas, indicate where knowledge is scarce and point out fertile grounds for future investigation.
MeSH Terms
Adenomatous Polyposis Coli Protein/metabolism
Apoptosis/genetics,physiology
DNA Repair/genetics,physiology
DNA-Binding Proteins/metabolism
Genes, Tumor Suppressor/physiology
Humans
Hypoxia-Inducible Factor 1
Hypoxia-Inducible Factor 1, alpha Subunit
Mutation/genetics
Neoplasms/genetics,metabolism
Nuclear Proteins/metabolism
Oncogenes/genetics,physiology
Phosphatidylinositol 3-Kinases/metabolism
Receptor Protein-Tyrosine Kinases/metabolism
Retinoblastoma Protein/metabolism
Signal Transduction/genetics,physiology
Smad Proteins
Trans-Activators/metabolism
Transcription Factors/metabolism
Tumor Suppressor Protein p53/metabolism
Zinc Finger Protein GLI1
Chemicals
Adenomatous Polyposis Coli Protein
DNA-Binding Proteins
GLI1 protein, human
HIF1A protein, human
Hypoxia-Inducible Factor 1
Hypoxia-Inducible Factor 1, alpha Subunit
Nuclear Proteins
Retinoblastoma Protein
Smad Proteins
Trans-Activators
Transcription Factors
Tumor Suppressor Protein p53
Zinc Finger Protein GLI1
Phosphatidylinositol 3-Kinases
Receptor Protein-Tyrosine Kinases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Vogelstein Bert
Howard Hughes Medical Institute and The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University Medical Institutions, Baltimore, Maryland 21231, USA. vogelbe@welch.jhu.edu
Kinzler Kenneth W